CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 42 filers reported holding ANGION BIOMEDICA CORP in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q1 2022$97,000
-27.1%
45,7540.0%0.00%
Q4 2021$133,000
-70.3%
45,7540.0%0.00%
Q3 2021$448,000
+3.5%
45,754
+37.8%
0.00%
Q2 2021$433,000
-31.3%
33,210
-4.6%
0.00%
Q1 2021$630,00034,8180.00%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q2 2021
NameSharesValueWeighting ↓
CM Management, LLC 600,000$552,0000.62%
Nantahala Capital Management 1,066,012$981,0000.06%
BVF INC/IL 1,071,297$986,0000.04%
Birchview Capital, LP 54,392$50,0000.04%
Park West Asset Management LLC 370,724$341,0000.02%
Cannell Capital 40,181$37,0000.01%
Patriot Financial Group Insurance Agency, LLC 36,500$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,000$161,0000.00%
Valeo Financial Advisors, LLC 63,659$59,0000.00%
Ergoteles LLC 78,857$73,0000.00%
View complete list of ANGION BIOMEDICA CORP shareholders